Clinical Trials Pharmacovigilance
The purpose of pharmacovigilance is to enhance patient care and patient safety in relation to the use of medicines according to the life cycle of a health product. During clinical trials, the investigator collects and analyzes data on serious adverse events (SAEs), determining whether the drug in question caused the SAEs. If they conclude that the negative side effects were causal, they are categorized as adverse drug reactions (ADRs).
Related Conference of Clinical Trials Pharmacovigilance
June 22-23, 2026
5th World Congress on Medicinal Chemistry and Computer Aided Drug Design
Paris, France
July 27-28, 2026
19th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Rome, Italy
July 27-28, 2026
26th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Rome, Italy
August 20-21, 2026
27th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
London, UK
August 20-21, 2026
29th International Conference and Exhibition on Pharmaceutical Formulations
London, UK
August 20-21, 2026
32nd International Conference on Advanced Clinical Research and Clinical Trials
London, UK
November 19-20, 2026
14th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Dubai, UAE
November 26-27, 2026
5th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland